| | | | | |
PRQR ProQR Therapeutics N.V. Ordinary Shares | £1,0990 | +0,34% | £122,46M | £484,67K | |
NAZ Nuveen Arizona Quality Municipal Income Fund | £9,7906 | +0,00% | £122,45M | £24,75K | |
| £1,8106 | +0,00% | £122,39M | £255,37K | |
AMWL American Well Corporation | £6,3035 | +0,00% | £122,37M | £115,12K | |
| £39,1625 | -0,04% | £122,32M | £5,215 | |
SPRO Spero Therapeutics, Inc. Common Stock | £2,0863 | +0,00% | £122,09M | £640,78 | |
| £1,2443 | -1,76% | £121,92M | £1,490 | |
NMP NMP Acquisition Corp. Class A Ordinary Shares | £7,6112 | -0,24% | £121,61M | £1,09K | |
GLQ Clough Global Equity Fund | £6,4377 | +0,00% | £121,60M | £47,40K | |
MNSB MainStreet Bancshares, Inc. Common Stock | £16,9361 | +0,27% | £121,38M | £266,74 | |
ORMP Oramed Pharmaceuticals Inc. | £2,7196 | +0,00% | £121,06M | £268,17K | |
CPSH CPS Technologies Corp. Common Stock | £5,8639 | +0,13% | £121,02M | £8,68K | |
NNY Nuveen New York Municipal Value Fund | £6,4078 | +0,00% | £120,87M | £15,28K | |
VTN Invesco Trust for Investment Grade New York Municipals | £8,2185 | +0,00% | £120,78M | £7,26K | |
KORE KORE Group Holdings, Inc. | £6,8475 | +0,00% | £120,30M | £17,79K | |
